comparemela.com

Latest Breaking News On - Jens lindberg - Page 6 : comparemela.com

Medivir to present at the Stockholm Corporate Finance Life Science Day

/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet.

Jens lindbergMagnus christensenNasdaq stockholmStockholm corporate finance life science daySmall cap

Medivir to present at the Erik Penser Bank Healthcare Day

/PRNewswire/ Medivir AB (Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical.

Jens lindbergMagnus christensenErik penser bank healthcare dayNasdaq stockholmSmall cap

Pia Baumann takes up her position as Chief Medical Officer

/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet.

Pia baumannTakeda incyteMagnus christensenJens lindbergKarolinska instituteNasdaq stockholmChief medical officerKarolinska hospitalVice president medicalLung cancerChief medicalSmall cap

Medivir has determined the recommended phase 2 dose for fostrox in combination with Lenvima in HCC

/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet.

United kingdomSouth koreaMagnus christensenJens lindbergNasdaq stockholmSmall cap

MEDIVIR AB - YEAR-END REPORT JANUARY - DECEMBER 2022

/PRNewswire/ Continued strong recruitment in the dose escalation part of the fostrox study. October – December Financial summary for the quarter Net.

Uli hacksellPia baumannKarl tobiesonRichard torgersonMagnus christensenJens lindbergAnders hallbergNomination committeeDrug administrationNordea investment fundsHealthinvest partnersChief medical officerInfex therapeuticsQualified infectious disease productYear end report januaryCancer summit

vimarsana © 2020. All Rights Reserved.